Drug Metabolism and Disposition: 8 (3)

Index by author

May 01, 1980; Volume 8,Issue 3

A

Al-Turk, W A
1. You have access
  Effect of acute and chronic estrone, estradiol, and estriol treatment on hepatic, pulmonary, and intestinal mixed-function mon-oxygenase activities in female rats.
  W A Al-Turk, S J Stohs and E B Roche
  
  Drug Metabolism and Disposition May 1980, 8 (3) 143-146; DOI: https://doi.org/10.1124/dmd.8.3.143
Andrews, P A
1. You have access
  Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography.
  P A Andrews, D E Brenner, F T Chou, H Kubo and N R Bachur
  
  Drug Metabolism and Disposition May 1980, 8 (3) 152-156; DOI: https://doi.org/10.1124/dmd.8.3.152
Arison, B H
1. You have access
  Identification of a glutathione conjugate of cambendazole formed in the presence of liver microsomes.
  D E Wolf, J A VandenHeuvel, T R Tyler, R W Walker, F R Koniuszy, V Gruber, B H Arison, A Rosegay, T A Jacob and F J Wolf
  
  Drug Metabolism and Disposition May 1980, 8 (3) 131-136; DOI: https://doi.org/10.1124/dmd.8.3.131
2. You have access
  The metabolic disposition of (S)-2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine in rats, dogs, and humans.
  S Vickers, C A Duncan, B H Arison, R O Davies, R Ferguson and A G Zacchei
  
  Drug Metabolism and Disposition May 1980, 8 (3) 163-167; DOI: https://doi.org/10.1124/dmd.8.3.163

B

Bachur, N R
1. You have access
  Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography.
  P A Andrews, D E Brenner, F T Chou, H Kubo and N R Bachur
  
  Drug Metabolism and Disposition May 1980, 8 (3) 152-156; DOI: https://doi.org/10.1124/dmd.8.3.152
Bigler, P
1. You have access
  Identification of mephenytoin metabolites in the dog.
  G Karlaganis, A Küpfer, J Bircher, U P Schlunegger, H Gfeller and P Bigler
  
  Drug Metabolism and Disposition May 1980, 8 (3) 173-177; DOI: https://doi.org/10.1124/dmd.8.3.173
Bindel, U
1. You have access
  Characterization of dog hepatic drug-metabolizing enzymes and resultant effects on benzo[a]pyrene metabolite pattern and mutagenicity.
  M D Golan, M Bücker, H U Schmassmann, D Raphael, R Jung, U Bindel, H O Brase, F Tegtmeyer, T Friedberg, J Lorenz, P Stasiecki and F Oesch
  
  Drug Metabolism and Disposition May 1980, 8 (3) 121-126; DOI: https://doi.org/10.1124/dmd.8.3.121
Bircher, J
1. You have access
  Identification of mephenytoin metabolites in the dog.
  G Karlaganis, A Küpfer, J Bircher, U P Schlunegger, H Gfeller and P Bigler
  
  Drug Metabolism and Disposition May 1980, 8 (3) 173-177; DOI: https://doi.org/10.1124/dmd.8.3.173
Brase, H O
1. You have access
  Characterization of dog hepatic drug-metabolizing enzymes and resultant effects on benzo[a]pyrene metabolite pattern and mutagenicity.
  M D Golan, M Bücker, H U Schmassmann, D Raphael, R Jung, U Bindel, H O Brase, F Tegtmeyer, T Friedberg, J Lorenz, P Stasiecki and F Oesch
  
  Drug Metabolism and Disposition May 1980, 8 (3) 121-126; DOI: https://doi.org/10.1124/dmd.8.3.121
Brenner, D E
1. You have access
  Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography.
  P A Andrews, D E Brenner, F T Chou, H Kubo and N R Bachur
  
  Drug Metabolism and Disposition May 1980, 8 (3) 152-156; DOI: https://doi.org/10.1124/dmd.8.3.152
Bücker, M
1. You have access
  Characterization of dog hepatic drug-metabolizing enzymes and resultant effects on benzo[a]pyrene metabolite pattern and mutagenicity.
  M D Golan, M Bücker, H U Schmassmann, D Raphael, R Jung, U Bindel, H O Brase, F Tegtmeyer, T Friedberg, J Lorenz, P Stasiecki and F Oesch
  
  Drug Metabolism and Disposition May 1980, 8 (3) 121-126; DOI: https://doi.org/10.1124/dmd.8.3.121

C

Chou, F T
1. You have access
  Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography.
  P A Andrews, D E Brenner, F T Chou, H Kubo and N R Bachur
  
  Drug Metabolism and Disposition May 1980, 8 (3) 152-156; DOI: https://doi.org/10.1124/dmd.8.3.152

D

Davies, R O
1. You have access
  The metabolic disposition of (S)-2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine in rats, dogs, and humans.
  S Vickers, C A Duncan, B H Arison, R O Davies, R Ferguson and A G Zacchei
  
  Drug Metabolism and Disposition May 1980, 8 (3) 163-167; DOI: https://doi.org/10.1124/dmd.8.3.163
Deeb, G
1. You have access
  Disposition of 14C-cefatrizine in man.
  R C Gaver and G Deeb
  
  Drug Metabolism and Disposition May 1980, 8 (3) 157-162; DOI: https://doi.org/10.1124/dmd.8.3.157
Duncan, C A
1. You have access
  The metabolic disposition of (S)-2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine in rats, dogs, and humans.
  S Vickers, C A Duncan, B H Arison, R O Davies, R Ferguson and A G Zacchei
  
  Drug Metabolism and Disposition May 1980, 8 (3) 163-167; DOI: https://doi.org/10.1124/dmd.8.3.163

F

Ferguson, R
1. You have access
  The metabolic disposition of (S)-2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine in rats, dogs, and humans.
  S Vickers, C A Duncan, B H Arison, R O Davies, R Ferguson and A G Zacchei
  
  Drug Metabolism and Disposition May 1980, 8 (3) 163-167; DOI: https://doi.org/10.1124/dmd.8.3.163
Friedberg, T
1. You have access
  Characterization of dog hepatic drug-metabolizing enzymes and resultant effects on benzo[a]pyrene metabolite pattern and mutagenicity.
  M D Golan, M Bücker, H U Schmassmann, D Raphael, R Jung, U Bindel, H O Brase, F Tegtmeyer, T Friedberg, J Lorenz, P Stasiecki and F Oesch
  
  Drug Metabolism and Disposition May 1980, 8 (3) 121-126; DOI: https://doi.org/10.1124/dmd.8.3.121

G

Gaver, R C
1. You have access
  Disposition of 14C-cefatrizine in man.
  R C Gaver and G Deeb
  
  Drug Metabolism and Disposition May 1980, 8 (3) 157-162; DOI: https://doi.org/10.1124/dmd.8.3.157
Gfeller, H
1. You have access
  Identification of mephenytoin metabolites in the dog.
  G Karlaganis, A Küpfer, J Bircher, U P Schlunegger, H Gfeller and P Bigler
  
  Drug Metabolism and Disposition May 1980, 8 (3) 173-177; DOI: https://doi.org/10.1124/dmd.8.3.173
Golan, M D
1. You have access
  Characterization of dog hepatic drug-metabolizing enzymes and resultant effects on benzo[a]pyrene metabolite pattern and mutagenicity.
  M D Golan, M Bücker, H U Schmassmann, D Raphael, R Jung, U Bindel, H O Brase, F Tegtmeyer, T Friedberg, J Lorenz, P Stasiecki and F Oesch
  
  Drug Metabolism and Disposition May 1980, 8 (3) 121-126; DOI: https://doi.org/10.1124/dmd.8.3.121
Gruber, V
1. You have access
  Identification of a glutathione conjugate of cambendazole formed in the presence of liver microsomes.
  D E Wolf, J A VandenHeuvel, T R Tyler, R W Walker, F R Koniuszy, V Gruber, B H Arison, A Rosegay, T A Jacob and F J Wolf
  
  Drug Metabolism and Disposition May 1980, 8 (3) 131-136; DOI: https://doi.org/10.1124/dmd.8.3.131

H

Harvey, D J
1. You have access
  Identification of in vivo liver metabolites of delta 6-tetrahydrocannabinol produced by the mouse.
  D J Harvey and W D Paton
  
  Drug Metabolism and Disposition May 1980, 8 (3) 178-186; DOI: https://doi.org/10.1124/dmd.8.3.178

J

Jacob, T A
1. You have access
  Identification of a glutathione conjugate of cambendazole formed in the presence of liver microsomes.
  D E Wolf, J A VandenHeuvel, T R Tyler, R W Walker, F R Koniuszy, V Gruber, B H Arison, A Rosegay, T A Jacob and F J Wolf
  
  Drug Metabolism and Disposition May 1980, 8 (3) 131-136; DOI: https://doi.org/10.1124/dmd.8.3.131
Jung, R
1. You have access
  Characterization of dog hepatic drug-metabolizing enzymes and resultant effects on benzo[a]pyrene metabolite pattern and mutagenicity.
  M D Golan, M Bücker, H U Schmassmann, D Raphael, R Jung, U Bindel, H O Brase, F Tegtmeyer, T Friedberg, J Lorenz, P Stasiecki and F Oesch
  
  Drug Metabolism and Disposition May 1980, 8 (3) 121-126; DOI: https://doi.org/10.1124/dmd.8.3.121

K

Karlaganis, G
1. You have access
  Identification of mephenytoin metabolites in the dog.
  G Karlaganis, A Küpfer, J Bircher, U P Schlunegger, H Gfeller and P Bigler
  
  Drug Metabolism and Disposition May 1980, 8 (3) 173-177; DOI: https://doi.org/10.1124/dmd.8.3.173
Koniuszy, F R
1. You have access
  Identification of a glutathione conjugate of cambendazole formed in the presence of liver microsomes.
  D E Wolf, J A VandenHeuvel, T R Tyler, R W Walker, F R Koniuszy, V Gruber, B H Arison, A Rosegay, T A Jacob and F J Wolf
  
  Drug Metabolism and Disposition May 1980, 8 (3) 131-136; DOI: https://doi.org/10.1124/dmd.8.3.131
Kubo, H
1. You have access
  Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography.
  P A Andrews, D E Brenner, F T Chou, H Kubo and N R Bachur
  
  Drug Metabolism and Disposition May 1980, 8 (3) 152-156; DOI: https://doi.org/10.1124/dmd.8.3.152
Küpfer, A
1. You have access
  Identification of mephenytoin metabolites in the dog.
  G Karlaganis, A Küpfer, J Bircher, U P Schlunegger, H Gfeller and P Bigler
  
  Drug Metabolism and Disposition May 1980, 8 (3) 173-177; DOI: https://doi.org/10.1124/dmd.8.3.173

L

Lorenz, J
1. You have access
  Characterization of dog hepatic drug-metabolizing enzymes and resultant effects on benzo[a]pyrene metabolite pattern and mutagenicity.
  M D Golan, M Bücker, H U Schmassmann, D Raphael, R Jung, U Bindel, H O Brase, F Tegtmeyer, T Friedberg, J Lorenz, P Stasiecki and F Oesch
  
  Drug Metabolism and Disposition May 1980, 8 (3) 121-126; DOI: https://doi.org/10.1124/dmd.8.3.121

M

Martz, F
1. You have access
  Metabolism and covalent binding of 1-(o-chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane (o,p,'-DDD). Correlation between adrenocorticolytic activity and metabolic activation by adrenocortical mitochondria.
  F Martz and J A Straw
  
  Drug Metabolism and Disposition May 1980, 8 (3) 127-130; DOI: https://doi.org/10.1124/dmd.8.3.127
Masters, B S
1. You have access
  Effect of phenobarbital treatment and cytochrome P-450 inhibitors on the laurate omega- and (omega - 1)-hydroxylase activities of rat liver microsomes.
  R T Okita and B S Masters
  
  Drug Metabolism and Disposition May 1980, 8 (3) 147-151; DOI: https://doi.org/10.1124/dmd.8.3.147

O

Oesch, F
1. You have access
  Characterization of dog hepatic drug-metabolizing enzymes and resultant effects on benzo[a]pyrene metabolite pattern and mutagenicity.
  M D Golan, M Bücker, H U Schmassmann, D Raphael, R Jung, U Bindel, H O Brase, F Tegtmeyer, T Friedberg, J Lorenz, P Stasiecki and F Oesch
  
  Drug Metabolism and Disposition May 1980, 8 (3) 121-126; DOI: https://doi.org/10.1124/dmd.8.3.121
Okita, R T
1. You have access
  Effect of phenobarbital treatment and cytochrome P-450 inhibitors on the laurate omega- and (omega - 1)-hydroxylase activities of rat liver microsomes.
  R T Okita and B S Masters
  
  Drug Metabolism and Disposition May 1980, 8 (3) 147-151; DOI: https://doi.org/10.1124/dmd.8.3.147
Olson, J W
1. You have access
  Inhibition of hepatic drug metabolism in VX2 carcinoma-bearing rabbits.
  M Weiner and J W Olson
  
  Drug Metabolism and Disposition May 1980, 8 (3) 139-142; DOI: https://doi.org/10.1124/dmd.8.3.139

P

Paton, W D
1. You have access
  Identification of in vivo liver metabolites of delta 6-tetrahydrocannabinol produced by the mouse.
  D J Harvey and W D Paton
  
  Drug Metabolism and Disposition May 1980, 8 (3) 178-186; DOI: https://doi.org/10.1124/dmd.8.3.178

R

Raphael, D
1. You have access
  Characterization of dog hepatic drug-metabolizing enzymes and resultant effects on benzo[a]pyrene metabolite pattern and mutagenicity.
  M D Golan, M Bücker, H U Schmassmann, D Raphael, R Jung, U Bindel, H O Brase, F Tegtmeyer, T Friedberg, J Lorenz, P Stasiecki and F Oesch
  
  Drug Metabolism and Disposition May 1980, 8 (3) 121-126; DOI: https://doi.org/10.1124/dmd.8.3.121
Roche, E B
1. You have access
  Effect of acute and chronic estrone, estradiol, and estriol treatment on hepatic, pulmonary, and intestinal mixed-function mon-oxygenase activities in female rats.
  W A Al-Turk, S J Stohs and E B Roche
  
  Drug Metabolism and Disposition May 1980, 8 (3) 143-146; DOI: https://doi.org/10.1124/dmd.8.3.143
Rosegay, A
1. You have access
  Identification of a glutathione conjugate of cambendazole formed in the presence of liver microsomes.
  D E Wolf, J A VandenHeuvel, T R Tyler, R W Walker, F R Koniuszy, V Gruber, B H Arison, A Rosegay, T A Jacob and F J Wolf
  
  Drug Metabolism and Disposition May 1980, 8 (3) 131-136; DOI: https://doi.org/10.1124/dmd.8.3.131
2. You have access
  4-Thio derivatives of cambendazole.
  A Rosegay
  
  Drug Metabolism and Disposition May 1980, 8 (3) 136-138; DOI: https://doi.org/10.1124/dmd.8.3.136

S

Schlunegger, U P
1. You have access
  Identification of mephenytoin metabolites in the dog.
  G Karlaganis, A Küpfer, J Bircher, U P Schlunegger, H Gfeller and P Bigler
  
  Drug Metabolism and Disposition May 1980, 8 (3) 173-177; DOI: https://doi.org/10.1124/dmd.8.3.173
Schmassmann, H U
1. You have access
  Characterization of dog hepatic drug-metabolizing enzymes and resultant effects on benzo[a]pyrene metabolite pattern and mutagenicity.
  M D Golan, M Bücker, H U Schmassmann, D Raphael, R Jung, U Bindel, H O Brase, F Tegtmeyer, T Friedberg, J Lorenz, P Stasiecki and F Oesch
  
  Drug Metabolism and Disposition May 1980, 8 (3) 121-126; DOI: https://doi.org/10.1124/dmd.8.3.121
Sporn, M B
1. You have access
  Pharmacokinetics of N-(4-hydroxyphenyl)-all-trans-retinamide in rats.
  B N Swanson, D W Zaharevitz and M B Sporn
  
  Drug Metabolism and Disposition May 1980, 8 (3) 168-172; DOI: https://doi.org/10.1124/dmd.8.3.168
Stasiecki, P
1. You have access
  Characterization of dog hepatic drug-metabolizing enzymes and resultant effects on benzo[a]pyrene metabolite pattern and mutagenicity.
  M D Golan, M Bücker, H U Schmassmann, D Raphael, R Jung, U Bindel, H O Brase, F Tegtmeyer, T Friedberg, J Lorenz, P Stasiecki and F Oesch
  
  Drug Metabolism and Disposition May 1980, 8 (3) 121-126; DOI: https://doi.org/10.1124/dmd.8.3.121
Stohs, S J
1. You have access
  Effect of acute and chronic estrone, estradiol, and estriol treatment on hepatic, pulmonary, and intestinal mixed-function mon-oxygenase activities in female rats.
  W A Al-Turk, S J Stohs and E B Roche
  
  Drug Metabolism and Disposition May 1980, 8 (3) 143-146; DOI: https://doi.org/10.1124/dmd.8.3.143
Straw, J A
1. You have access
  Metabolism and covalent binding of 1-(o-chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane (o,p,'-DDD). Correlation between adrenocorticolytic activity and metabolic activation by adrenocortical mitochondria.
  F Martz and J A Straw
  
  Drug Metabolism and Disposition May 1980, 8 (3) 127-130; DOI: https://doi.org/10.1124/dmd.8.3.127
Swanson, B N
1. You have access
  Pharmacokinetics of N-(4-hydroxyphenyl)-all-trans-retinamide in rats.
  B N Swanson, D W Zaharevitz and M B Sporn
  
  Drug Metabolism and Disposition May 1980, 8 (3) 168-172; DOI: https://doi.org/10.1124/dmd.8.3.168

T

Tegtmeyer, F
1. You have access
  Characterization of dog hepatic drug-metabolizing enzymes and resultant effects on benzo[a]pyrene metabolite pattern and mutagenicity.
  M D Golan, M Bücker, H U Schmassmann, D Raphael, R Jung, U Bindel, H O Brase, F Tegtmeyer, T Friedberg, J Lorenz, P Stasiecki and F Oesch
  
  Drug Metabolism and Disposition May 1980, 8 (3) 121-126; DOI: https://doi.org/10.1124/dmd.8.3.121
Tyler, T R
1. You have access
  Identification of a glutathione conjugate of cambendazole formed in the presence of liver microsomes.
  D E Wolf, J A VandenHeuvel, T R Tyler, R W Walker, F R Koniuszy, V Gruber, B H Arison, A Rosegay, T A Jacob and F J Wolf
  
  Drug Metabolism and Disposition May 1980, 8 (3) 131-136; DOI: https://doi.org/10.1124/dmd.8.3.131

V

VandenHeuvel, J A
1. You have access
  Identification of a glutathione conjugate of cambendazole formed in the presence of liver microsomes.
  D E Wolf, J A VandenHeuvel, T R Tyler, R W Walker, F R Koniuszy, V Gruber, B H Arison, A Rosegay, T A Jacob and F J Wolf
  
  Drug Metabolism and Disposition May 1980, 8 (3) 131-136; DOI: https://doi.org/10.1124/dmd.8.3.131
Vickers, S
1. You have access
  The metabolic disposition of (S)-2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine in rats, dogs, and humans.
  S Vickers, C A Duncan, B H Arison, R O Davies, R Ferguson and A G Zacchei
  
  Drug Metabolism and Disposition May 1980, 8 (3) 163-167; DOI: https://doi.org/10.1124/dmd.8.3.163

W

Walker, R W
1. You have access
  Identification of a glutathione conjugate of cambendazole formed in the presence of liver microsomes.
  D E Wolf, J A VandenHeuvel, T R Tyler, R W Walker, F R Koniuszy, V Gruber, B H Arison, A Rosegay, T A Jacob and F J Wolf
  
  Drug Metabolism and Disposition May 1980, 8 (3) 131-136; DOI: https://doi.org/10.1124/dmd.8.3.131
Weiner, M
1. You have access
  Inhibition of hepatic drug metabolism in VX2 carcinoma-bearing rabbits.
  M Weiner and J W Olson
  
  Drug Metabolism and Disposition May 1980, 8 (3) 139-142; DOI: https://doi.org/10.1124/dmd.8.3.139
Wolf, D E
1. You have access
  Identification of a glutathione conjugate of cambendazole formed in the presence of liver microsomes.
  D E Wolf, J A VandenHeuvel, T R Tyler, R W Walker, F R Koniuszy, V Gruber, B H Arison, A Rosegay, T A Jacob and F J Wolf
  
  Drug Metabolism and Disposition May 1980, 8 (3) 131-136; DOI: https://doi.org/10.1124/dmd.8.3.131
Wolf, F J
1. You have access
  Identification of a glutathione conjugate of cambendazole formed in the presence of liver microsomes.
  D E Wolf, J A VandenHeuvel, T R Tyler, R W Walker, F R Koniuszy, V Gruber, B H Arison, A Rosegay, T A Jacob and F J Wolf
  
  Drug Metabolism and Disposition May 1980, 8 (3) 131-136; DOI: https://doi.org/10.1124/dmd.8.3.131

Z

Zacchei, A G
1. You have access
  The metabolic disposition of (S)-2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine in rats, dogs, and humans.
  S Vickers, C A Duncan, B H Arison, R O Davies, R Ferguson and A G Zacchei
  
  Drug Metabolism and Disposition May 1980, 8 (3) 163-167; DOI: https://doi.org/10.1124/dmd.8.3.163
Zaharevitz, D W
1. You have access
  Pharmacokinetics of N-(4-hydroxyphenyl)-all-trans-retinamide in rats.
  B N Swanson, D W Zaharevitz and M B Sporn
  
  Drug Metabolism and Disposition May 1980, 8 (3) 168-172; DOI: https://doi.org/10.1124/dmd.8.3.168

Main menu

User menu

Search

Index by author

A

Al-Turk, W A

Andrews, P A

Arison, B H

B

Bachur, N R

Bigler, P

Bindel, U

Bircher, J

Brase, H O

Brenner, D E

Bücker, M

C

Chou, F T

D

Davies, R O

Deeb, G

Duncan, C A

F

Ferguson, R

Friedberg, T

G

Gaver, R C

Gfeller, H

Golan, M D

Gruber, V

H

Harvey, D J

J

Jacob, T A

Jung, R

K

Karlaganis, G

Koniuszy, F R

Kubo, H

Küpfer, A

L

Lorenz, J

M

Martz, F

Masters, B S

O

Oesch, F

Okita, R T

Olson, J W

P

Paton, W D

R

Raphael, D

Roche, E B

Rosegay, A

S

Schlunegger, U P

Schmassmann, H U

Sporn, M B

Stasiecki, P

Stohs, S J

Straw, J A

Swanson, B N

T

Tegtmeyer, F

Tyler, T R

V

VandenHeuvel, J A

Vickers, S

W

Walker, R W

Weiner, M

Wolf, D E

Wolf, F J

Z

Zacchei, A G

Zaharevitz, D W

In this issue

Navigate

More Information